+264.6%
ASTS vs THC
+1,038.9%
-774.3%
-91.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.1% | +9.6% | -13.7% | -5.8% |
| 7D | -15.8% | +8.8% | -24.6% | -17.1% |
| 30D | -39.0% | +12.6% | -51.7% | -40.4% |
| 3M | -49.3% | +15.4% | -64.7% | -50.8% |
| 6M | -47.9% | +57.7% | -105.6% | -52.9% |
| YTD | -51.0% | +47.1% | -98.0% | -55.2% |
| 1Y | -49.2% | +40.7% | -89.8% | -53.1% |
| 3Y | +760.4% | +432.1% | +328.2% | +513.3% |
| 5Y | +185.6% | +301.9% | -116.2% | +109.0% |
| All | +264.6% | +1,038.9% | -774.3% | +170.1% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling